Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients

  • Masayoshi Harigai, Tsuyoshi Tsuchiya, Katsuyoshi Kawana, Sarina Kurimoto
  • Modern Rheumatology, April 2017, Taylor & Francis
  • DOI: 10.1080/14397595.2017.1304159

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/14397595.2017.1304159